Major Depression as a Risk Factor for Cardiovascular Disease: Therapeutic Implications

Heart Disease

Volumn 2, Issue 1, 2000, Pages 75-82

  Perlmutter, Julia B ^a   Frishman, William H ^b   Feinstein, Robert E ^b  

^a NEW YORK PRESBYTERIAN HOSPITAL   (United States)

^b WESTCHESTER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOVASCULAR DISEASE; DEPRESSION; HUMAN; REVIEW; RISK FACTOR;

CARDIOVASCULAR DISEASES; DEPRESSIVE DISORDER; HUMAN; RISK FACTORS;

EID: 0033763113     PISSN: 1521737X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (112)

1. Kannel WB, Wolf PA, Veter I, Mcnamara PM. Epidemiologic assessment of the role of blood pressure in stroke: the Framingham study. JAMA 1970;214: 301-310.
2. Veterans Administration and Co-operative Study Group on Antihypertensive Agents. Effects of treatment on morbidity in hypertension; results in patients with diastolic blood pressures averaging 115 through 129 mmHg. JAMA 1967;202:116-122.
3. Hypertension Detection and Follow-up Program Cooperative Group. Persistence of reduction in blood pressure and mortality of participants in the Hypertension Detection and Followup Program. JAMA 1988;259:2113-2122.
4. Multiple Risk Factor Intervention Trial Research Group. Multiple risk intervention trial: risk factor changes and mortality results. JAMA 1982;248:1465-1467.
5. Hopkins PN, Williams RR. A survey of 246 suggested coronary risk factors. Atherosclerosis 1981;40:1-52.
6. Carney RM, Freedland KE, Sheline YI, Weiss ES. Depression and coronary heart disease: a review for cardiologists. Clin Cardiol 1997;20:196-200.
7. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. Third edition (DSM III). Washington, DC: American Psychiatric Association, 1980.
8. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. Third edition revised (DSM III-R). Washington, DC: American Psychiatric Association, 1987.
9. Rabkin JG, Charles E, Kass F. Hypertension and DSM-III depression in psychiatric outpatients. Am J Psychiatry 1983;140:1072-1074.
10. Noyes R, Woodman C, Garvey MJ, Cook BL, Suelzer M, Clancy J, Anderson DJ. Generalized panic disorder versus panic disorder: distinguishing characteristics and patterns of comorbidity. J Nerv Ment Dis 1992;180:369-379.
11. Fuller BF. DSM-III depression and hypertension in two psychiatric outpatient populations. Psychosomatics 1988;29:417-423.
12. Hyapa L, Ananth J. Depression associated with hypertension: a review. Psychiatric J University of Ottowa 1980;5:58-62.
13. Freedland KE, Carney RM, Lustman PJ, Rich MW, Jaffe AS. Major depression in coronary artery disease patients with vs without a prior history of depression. Psychosomatic Med 1992;4:416-421.
14. Gonzalez MB, Snyderman TB, Colket JT, Arias RM, Jiang JW, O'Connor CM, Krishan KR. Depression in patients with coronary artery disease. Depression 1996;4:57-62.
15. Carney RM, Rich MW, Tevelde MA, Saini J, Clark K, Jaffen A. Major depressive disorder in coronary artery disease. Am J Cardiol 1987;60:1273-1275.
16. Hance M, Carney RM, Freedland KE, Skala J. Depression in patients with coronary artery disease: a 12 month followup. Gen Hosp Psychiatry 1996;18: 61-65.
17. McKhann GM, Borowicz LM, Goldsborough MA, Enger C, Selnes OA. Depression and cognitive decline after coronary artery bypass grafting. Lancet 1997;349:1282-1284.
18. Blazer DTG, Keller RC, McGonagle KA, Swartz MS. The prevalence and distribution of major depression in a national community sample: the national comorbidity survey. Am J Psychiatry 1994;151:979-986.
19. Pratt LA, Ford DE, Crum RM, Armenian HK, Gallo JJ, Eaton WW. Depression, psychotropic medication, and risk of myocardial infarction: prospective data from the Baltimore ECA follow-up. Circulation 1996;94:3123-3129.
20. Anda R, Williamson D, Jones D, Macera C, Eaker E, Glassman A. Depressed affect, hopelessness, and the risk of ischemic heart disease in a cohort of U.S. adults. Epidemiology 1993;4:285-289.
21. Ford DE, Mead LA, Chang PP, Cooper-Patrick L, Wang NY, Klag MJ. Depression is a risk factor for coronary artery disease in men: the precursors study. Arch Intern Med 1998;158:1422-1426.
22. Aromma A, Rasitsolo R, Heliovaara M, Knekt P, Lehtinen V, Joukamaa M. Depression and cardiovascular diseases. Acta Psychiatr Scand 1994; 377(suppl):77-78.
23. Sesso HD, Kawachi I, Vokonas PS, Sparrow D. Depression and the risk of coronary heart disease in the normative aging study. Am J Cardiol 1998;82: 851-856.
24. Pennix BW, Guralnik JM, Mendes de Leon CF, Pahor M, Visser M, Corti M, et al. Cardiovascular events and mortality in newly and chronically depressed persons >70 years of age. Am J Cardiol 1998;81:988-994.
25. Mendes de leon CF, Krumholz HM, Seeman TS, Vaccarino V, Williams CS, Kasl SV, et al. Depression and risk of coronary heart disease in elderly men and women: New Haven EPESE, 1982-1991. Arch Intern Med 1998;158:2341-2348.
26. Whooley MA, Browner WS. Association between depressive symptoms and mortality in older women. Arch Intern Med 1998;158:2129-2135.
27. Barefoot JC, Schroll M. Symptoms of depression, acute myocardial infarction, and total mortality in a community sample. Circulation 1996;93:1976-1980.
28. Everson SA, Kaplan GA, Goldberg DE. Depressive symptoms and risk of myocardial infarction and mortality (abstract). Am J Epidemiol 1995;141:S37.
29. Barefoot JC, Helms MJ, Mark DB, Blumenthal JA, Califf RM, Haney TL, et al. Depression and long term mortality risk in patients with coronary artery disease. Am J Cardiol 1996;78:613-617.
30. Carney RM, Rich MW, Tevelde A, Sainin J, Clark K, Jaffe AS. Major depressive disorder predicts cardiac events in patients with coronary artery disease. Psychosom Med 1988;50:627-633.
31. Levine JB, Covino NA, Slack WV, Safran C, Safran DB, Boro JE, et al. Psychological predictors of subsequent medical care among patients hospitalized with cardiac disease. J Cardiopulmonary Rehabil 1996;16:109-116.
32. Kennedy GJ, Hofer MA, Cohen D, Shindledecker R, Fisher JD. Significance of depression and cognitive impairment in patients undergoing programmed stimulation of cardiac arrhythmias. Psychosomatic Med 1987;49:410-412.
33. Sullivan MD, Lacroix AZ, Baum C, Grothaus LC, Katon WJ. Functional status in coronary artery disease: a one year prospective study of the role of anxiety and depression. Excerpta Medica 1997;103:348-356.
34. Simsonick EM, Wallace RB, Blazer DG, Berkman LF. Depressive symptomatology and hypertension associated morbidity and mortality in older adults. Psychosomatic Med 1995;57:427-435.
35. Denollet J, Sys SU, Brutsaert DL. Personality and mortality after myocardial infarction. Psychosomatic Med 1995;57:582-591.
36. Forrester AW, Lipsey JR, Teitlbaum ML, DePaulo JR, Andrzejewski PL, Robinson RG. Depression following myocardial infarction. Int J Psychiatry Med 1992;22:33-46.
37. Lloyd GG, Cawley RH. Distress or illness? A study of psychosocial symptoms after myocardial infarction. Br J Psychiatry 1983;142:120-125.
38. Kurosawa H, Shimizu Y, Nishimatsu Y, Hirose S, Takano T. The relationship between mental disorders and physical severities in patients with myocardial infarction. Jpn Circ Res 1983;47:723-728.
39. Cay EL, Vetter N, Philip AE, Dugard P. Psychological status during recovery from an acute heart attack. J Psychosom Res 1972;16:425-435.
40. Schleifer SJ, Macari-Hinson MM, Coyle DA, Slater WR, Kahn M, Gorlin R, et al. The nature and course of depression following myocardial infarction. Arch Intern Med 1989;149:1785-1789.
41. Havik OE and Maeland JG. Patterns of emotional reactions after a myocardial infarction. J Psychosom Res 1990;34:271-285.
42. Frasure-Smith N, Lesperance F, Taljaic M. Depression following myocardial infarction: impact on 6-month survival. JAMA 1993;270:1819-1825.
43. Frasure-Smith N, Lesperance F, Taljaic M. Depression and 18 month prognosis after myocardial infarction. Circulation 1995;91:999-1005.
44. Lesperance F, Frasure-Smith X, Taljaic M. Major depression before and after myocardial infarction: its nature and consequences. Psychosom Med 1996;58: 99-110.
45. Silverstone PH. Depression and outcome in acute myocardial infarction. BMJ 1987;24:219-220.
46. Ladwig KH, Kieser M, Konig J, Breithardt G, Borggrefe M. Affective disorders and survival after acute myocardial infarction: results from the post infarction late potential study. Eur Heart J 1991;12:959-964.
47. Ladwig KH, Roll G, Breithardt G, Budde T, Borggrefe M. Post infarction depression and incomplete recovery 6 months after acute myocardial infarction. Lancet 1994;343:20-23.
48. Ahern DK, Gorkin L, Anderson JL, Tierney C, Hallstrom A, Ewart C, et al. Biobehavioral variables and mortality: or cardiac arrest in the cardiac arrhythmia pilot study. Am J Cardiol 1990;59:58-62.
49. Appels A. Mental precursors of myocardial infarction. Br J Psychiatry 1990; 156:465-471.
50. Wassertheil-Smoler S, Applegate WB, Berge K, Chang CJ, Davis BR, Grimm R, et al. Change in depression as a precursor of cardiovascular events. Arch Intern Med 1996;156:553-561.
51. Barry J, Selwyn AP, Nabel EG, Rocco MB, Mead K, Campbell S, et al. Frequency of ST-segment depression produced by mental stress in stable angina pectoris from coronary artery disease. Am J Cardiol 1988;61:989-993.
52. Gullette E, Blumenthal JA, Babyack M, Jiang W, Waugh RA, Frid, et al. Effects of mental stress on myocardial ischemia during daily life. JAMA 1997;277: 1521-1526.
53. Legalt SE, Langer A, Armstrong PW, Freeman MR. Usefulness of ischemis repsonse to mental stress in predicting silent myocardial ischemia during ambulatory monitoring. Am J Cardiol 1995;75:1007-1011.
54. Rocco MB, Nabel FG, Campbell S, Goldman L, Barry J, Mead K, et al. Prognostic importance of myocardial ischemia detected by ambulatory monitoring in patients with stable coronary artery disease. Circulation 1988;78: 877-884.
55. Blumenthal JA, Jiang W, Waugh RA, Frid DJ, Morris JJ, Coleman E, et al. Mental stress-induced ischemia in the laboratory and ambulatory ischemia in everyday life: association and hemodynamic factors. Circulation 1995; 92:2102-2108.
56. Burg MM, Jain D, Soufer R, Kerns RD, Zaret BL. Role of behavioral and psychological factors in mental stress induced silent left ventricular dysfunction in coronary artery disease. J Am Coll Cardiol 1993;22:440-448.
57. Musselman DL, Nemeroff CB. Depression and cardiovascular disease: increasing evidence of a connection. Cardiovasc Rehabil Recovery 1998:34-42.
58. Vieth R, Lewis N, Linares OA, Barnes RF, Raskind MA, Villacres EC, et al. Sympathetic nervous system activity in major depression: basal and desipramine-induced alterations in plasma norepinehrine kinetics. Arch Gen Psychiatry 1994;51:411-422.
59. Fleming R, Baum A, Gisriel MM, Gatchel RJ. Mediating influences of social support on stress at three mile island. J Hum Stress 1982;8:14-22.
60. Suarez EC. Hostility related differences in urinary excretion rates of catecholamines. Presented at the annual meeting of the Society for Psychophysiological Research, Chicago, IL, 1992.
61. Lechin F, van der Dijs B, Orzco B. Plasma neurotransmitters, blood pressure, and heart rate during supine-resting, orthostasis, and moderate exercise conditions in major depressed patients. Biol Psychiatry 1995;38:166-173.
62. 2 in patients with depression. Am J Med Sci 1994;307:228-232.
63. Sachar EJ, Hellman L, Fukushima DK, Gallagher TF. Cortisol production in depressive illness: a clinical and biochemical clarification. Arch Gen Psychiatry 1970;23:289-298.
64. Pfhol B, Rederer M, Coryell W, Stangl D. Association between post dexamethasone cortisol level and blood pressure management in depressed inpatients. J Nerv Ment Dis 1991;178:44-47.
65. Radsheer FC, Hoogendijk WJG, Stam FC, Tilders FJH, Swaab DF. Increased numbers of corticotropin-releasing hormone expressing neurons in the hypothalamic paraventricular nucleus of depressed patients. Neuroendocrinology 1994;60:436-444.
66. Radsheer FC, van Heerikhuize JJ, Lucassen PJ, Hocgendijk WF, Tilders FJH, Swaab DF. Corticotropin releasing hormone mRNA levels in the paraventricular nucleus of patients with Alzheimer's disease and depression. Am J Psychiatry 1995;152:1372-1376.
67. Guinjoan SM, Bernabo JL, Cardinali DP. Cardiovascular tests of autonomic function and sympathetic skin responses in patients with major depression. J Neurol Neurosurg Psychiatry 1995;58:299-302.
68. Bigger JT, Kleiger RE, Fleiss JL. Components of heart rate variability measured during healing of acute myocardial infarction. Am J Cardiol 1988;61: 208-215.
69. Dalack GW, Roose SF. Perspectives in the relationship between cardiovascular disease and affective disorder. J Clin Psychiatry 1990;51(suppl):4-9.
70. Carney RM, Saunders RD, Freedland KE, Stein P, Rich MW, Jaffe AS. Association of depression with reduced heart rate variability in coronary artery disease. Am J Cardiol 1995;76:562-564.
71. Rechlin T, Weis M, Spitzer A, Kaschka WP. Are affective disorders associated with alterations of heart rate variability? J Affect Disord 1994;32:271-275.
72. Flores NA, Sheridan DJ. The pathophysiological role of platelets during myocardial ischemia. Cardiovasc Res 1994;28;295-302.
73. Laghrissi-Thode F, Wagner WR, Pollock BG, Johnson PC, Finkel MS. Elevated platelet factor 4 and beta thromboglobulin plasma levels in depressed patients with ischemic heart disease. Biol Psychiatry 1997;42:290-295.
74. Mikuni M, Kagya A, Takahashi K, Meltzer HY. Serotonin but not epinephrine induced calcium mobilization of platelets is enhanced in affective disorders. Psychopharmacology 1992;106:311-314.
75. Glassman AH, Helzer JE, Covey LS, Cottler LB, Stetner F, Tipp JE, Johnson J. Smoking, smoking cessation, and major depression. JAMA 1990;264: 1546-1549.
76. Helmers KF, Krantz DS, Howell RH, Klein J, Bairey CK, Rozanski A. Hostility and myocardial ischemia in coronary heart disease patients: evaluation by gender and ischemic index. Psychosomatic Med 1993;55:29-36.
77. Carney RM, Freedland KE, Eisen SA, Rich MW, Jaffe AS. Major depression and medication adherence in elderly patients with coronary artery disease. Health Psychol 1995;14:88-90.
78. Sheline YI, Freedland KE, Carney RM. How safe are serotonin reuptake inhibitors for depression in patients with cardiovascular disease? Am J Med 1997; 102:54-59.
79. Freedland KE, Lustman PF, Carney RM, Hong BA. Underdiagnosis of depression in patients with coronary artery disease: the role of nonspecific symptoms. Int J Psychiatry Med 1992;2:221-229.
80. Frishman WH, Nurenberg JR, Frishman E. Cardiovascular considerations with the use of psychoactive medications. In: Frishman WH, Sonnenblick EH (eds). Cardiovascular Pharmacotherapeutics. New York: McGraw Hill, 1997;1039-1052.
81. Buff DD, Brenner R, Kirtane SS, Gilboa R. Dysrhythmia associated with fluoxetine treatment in an elderly patient with cardiac disease. J Clin Psychiatry 1991;52:174-176.
82. Ahmed I, Dagincourt PG, Miller LG, Shader RI. Possible interaction between fluoxetine and pimozide causing sinus bradycardia. Can J Psychiatry 1993;38: 62-63.
83. Roberge RJ, Martin TJ. Mixed fluoxetine/loxapine overdose and atrial flutter. Ann Emerg Med 1994;23:586-590.
84. Amital D, Amital H, Gross R, Kindler S, Zohar J. Sinus bradycardia due to fluvoxamine overdose. Br J Psychiatry 1994;165:553-554. Letter.
85. Hillis LD, Lange RA. Serotonin and acute ischemic heart disease. N Engl J Med 1991;324:688-689.
86. Sheline YI, Freedland KE, Carney RM. How safe are serotonin reuptake inhibitors for depression in patients with coronary heart disease. Am J Med 1997;102:54-59.
87. Stoudemire A. Expanding psychopharmacologic treatment options for the depressed medical patient. Psychosomatics 1995;36:S19-S26.
88. Roose SP, Glassman AH, Attia E, Woodring S, Giardina EGV, Bigger JT. Cardiovascular effects of fluoxetine in depressed patients with heart disease. Am J Psychiatry 1998;155:660-665.
89. Roose SP, Laghrissi-Thode F, Kennedy JS, Nelson CN, Bigger JT, Pollock BG. Comparison of paroxetine and nortriptyline in depressed patients with cardiovascular disease. JAMA 1998;79:287-291.
90. Shapiro PA, Glassman AH, Lesperance F, O'Connor CM, Baker B, Lidagoster L, et al. Treatment of major depression after acute myocarclial infarction with sertraline: a preliminary study. In: Proceedings of the American Psychiatric Association. New York: American Psychiatric Association. 1996;249-250.
91. Roose SP, Devanand D, Suthers K. Depression: treating the patient with comorbid cardiac disease. Geriatrics 1999;54:20-35.
92. Lane RM, Sweeney M, Henry JA. Pharmacotherapy of the depressed patient with cardiovascular and/or cerebrovascular illness. Br J Clin Pract 1994;48:257-262.
93. Bannister SJ, Houser VP, Hulse JD. Evaluation of the potential for interactions of paroxetine with diazepam, cimetidine, warfarin, and digoxin. Acta Psychiatr Scand 1989;80(suppl):102-106.
94. Claire RJ, Servis ME, Cram DL. Potential interactions between warfarin sodium and fluoxetine (letter). Am J Psychiatry 1991;148:1604.
95. Holliday SM, Benfield P. Venlafaxine: a review of its pharmacology and therapeutic potential in depression. Drugs 1995;49:280-294.
96. Fawcett J, Barkin RL. Review of the results from clinical studies on the efficacy, safety and tolerability of mirtazapine for the treatment of major depression. J Affective Disord 1998;51:267-285.
97. Albers LJ, Hahn RK, Reist C. Handbook of Psychiatric Drugs. 1998-1999 edition. Current Clinical Strategies Publishing, 1999.
98. Hyman SE, Arana GW, Rosenbaum JF. Handbook of Psychiatric Drug Therapy. Third edition. Boston: Little Brown and Company, 1995.
99. Hughes JR. Smoking Cessation. N Engl J Med 1999;341:610-611.
100. Martyn R, Somberg JC, Kerin NZ. Proarrhythmia of nonantiarrhythmic drugs. Am Heart J 1993;126:201-205.
101. Haria M, Fitton A, McTavish D. Trazadone: a review of its pharmacology, therapeutic use in depression and therapeutic potential in other disorders. Drugs Aging 1994;4:331-355.
102. Andrews JM, Nemeroff CB. Contemporary management of depression. Am J Med 1994;97(suppl 6A):24-32.
103. Fontaine R, Ontiveros A, Elie R, Kensler TT, Roberts DL, Kaplita S, et al. A double blind comparison of nefazodone, impramine and placebo in major depression. J Clin Psychiatry 1994;55:234-241.
104. Rickels K, Schweizer E, Clary C, Fox I, Weise C. Nefazadone and imipramine in major depressions placebo controlled trial. Br J Psychiatry 1994;164:802-805.
105. Dopheide JA, Stimmel GL, Yi DD. Focus on nefazodone: a serotonergic drug for depression. Hosp Formulary 1995:30;205.
106. Salazar DE, Dockens RC, Milbrath RL, Raymond RH, Fulmor IE, Chaikin PC, Underman HD. Pharmacokinetic and pharmacodynamic evaluation of warfarin and nefazodone coadministration in healthy subjects. J Clin Pharmacol 1995;35:730-738.
107. Stoudemire A, Atkinson P. Use of cyclic antidepressants in patients with car diac conduction disturbances. Gen Hosp Psychiatry 1988;10:389-397.
108. Chitka DS. Cardiovascular effects of antidepressants: recognition and control. Geriatrics 1990;45:55-67.
109. Burrows GD, Norman TR, Dennerstein L, Davies BM. Antidepressant therapy: benefits and risks in perspective. Acta Psychiatry Scand 1985;320(suppl): 72:43-47.
110. Frasure-Smith N, Prince R. The ischemic heart disease life stress monitoring program: impact on mortality. Psychosomatic Med 1985;47:431-445.
111. Friedman M, Thoreson CE, Gill JJ, Powell LH, Ulmer D, Thompson L, et al. Alteration of type A behavior and reduction in cardiac recurrences in postmyocardial infarction patients. Am Heart J 1984;108:237-248.
112. Ornish D, Brown SE, Schwartz LW, Billings JH, Armstrong WT, Ports TA, et al. Can lifestyle changes reverse coronary heart disease? The lifestyle heart trial. Lancet 1990;336:129-132.